MedPath

POLYACTIVA PTY LTD

POLYACTIVA PTY LTD logo
πŸ‡¦πŸ‡ΊAustralia
Ownership
-
Employees
-
Market Cap
-
Website

Evaluate Efficacy, Safety, Tolerability and Biodegradation of PA5346 Ocular Implant in Patients With Open-Angle Glaucoma or Ocular Hypertension

Phase 1
Not yet recruiting
Conditions
Open Angle Glaucoma (OAG)
Ocular Hypertension (OH)
First Posted Date
2025-05-09
Last Posted Date
2025-05-09
Lead Sponsor
PolyActiva Pty Ltd
Target Recruit Count
12
Registration Number
NCT06964061

Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension

Phase 2
Not yet recruiting
Conditions
Glaucoma, Open-Angle
Ocular Hypertension
Interventions
Combination Product: PA5108 Ocular Implant low dose
Combination Product: PA5108 Ocular Implant, high dose
First Posted Date
2025-05-09
Last Posted Date
2025-05-09
Lead Sponsor
PolyActiva Pty Ltd
Target Recruit Count
75
Registration Number
NCT06964191

A Study of Levofloxacin Ocular Implant in Patients Undergoing Routine Bilateral Cataract Surgery

Phase 1
Withdrawn
Conditions
Cataract
Interventions
First Posted Date
2022-07-01
Last Posted Date
2024-04-12
Lead Sponsor
PolyActiva Pty Ltd
Registration Number
NCT05441930
Locations
πŸ‡ΊπŸ‡Έ

Carolina Cataract and Laser Centre, Ladson, South Carolina, United States

πŸ‡ΊπŸ‡Έ

Ophthalmology Associates, Saint Louis, Missouri, United States

πŸ‡¦πŸ‡Ί

Melbourne Eye Specialists, Fitzroy, Victoria, Australia

Study of a Latanoprost Ocular Implant for Treatment of Open Angle Glaucoma or Ocular Hypertension.

Phase 1
Completed
Conditions
Open Angle Glaucoma
Ocular Hypertension
Interventions
Drug: 100ng/day PA5346 Latanoprost FA SR Ocular Implant
First Posted Date
2022-04-19
Last Posted Date
2024-04-12
Lead Sponsor
PolyActiva Pty Ltd
Target Recruit Count
1
Registration Number
NCT05333419
Locations
πŸ‡³πŸ‡Ώ

Capital Eye Specialists, Te Aro, Wellington, New Zealand

πŸ‡³πŸ‡Ώ

Rotorua Eye Clinic, Rotorua, New Zealand

Levofloxacin Ocular Implant for Ocular Surgery

Phase 1
Completed
Conditions
Cataract
Interventions
First Posted Date
2020-12-23
Last Posted Date
2021-12-08
Lead Sponsor
PolyActiva Pty Ltd
Target Recruit Count
5
Registration Number
NCT04682288
Locations
πŸ‡ΊπŸ‡Έ

Ophthalmology Consultants Ltd, Saint Louis, Missouri, United States

πŸ‡ΊπŸ‡Έ

Carolina Cataract and Laser Centre, Ladson, South Carolina, United States

πŸ‡¦πŸ‡Ί

Melbourne Eye Specialists, Fitzroy, Victoria, Australia

Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucoma

Phase 1
Active, not recruiting
Conditions
Open Angle Glaucoma
Interventions
Drug: PA5108 Latanoprost FA SR Ocular Implant
First Posted Date
2019-08-19
Last Posted Date
2024-04-12
Lead Sponsor
PolyActiva Pty Ltd
Target Recruit Count
37
Registration Number
NCT04060758
Locations
πŸ‡¦πŸ‡Ί

PersonalEYES, Castle Hill, New South Wales, Australia

πŸ‡¦πŸ‡Ί

Goodwood Eye Centre, Millswood, South Australia, Australia

πŸ‡³πŸ‡Ώ

Capital Eye Specialists, Te Aro, New Zealand

and more 6 locations

Safety and Tolerability of a Prostaglandin Ocular Implant for Treatment of Open Angle Glaucoma

Phase 1
Completed
Conditions
Open-angle Glaucoma
Interventions
First Posted Date
2018-07-27
Last Posted Date
2020-09-16
Lead Sponsor
PolyActiva Pty Ltd
Target Recruit Count
8
Registration Number
NCT03604328
Locations
πŸ‡¦πŸ‡Ί

Melbourne Eye Specialists, Melbourne, Victoria, Australia

πŸ‡¦πŸ‡Ί

Centre for Eye Research Australia, East Melbourne, Victoria, Australia

Β© Copyright 2025. All Rights Reserved by MedPath